The evolution of renal function in the Czech cohort of patients with Fabry disease

被引：0
|
作者：
Dostalova, G. [1 ]
Kuchynka, P. [1 ]
Palecek, T. [1 ]
Lubanda, J. C. [1 ]
Bultas, J. [1 ]
Golan, L. [1 ]
Linhart, A. [1 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Gen Teaching Hosp, Dept Med 2,Clin Dept Cardiol & Angiol, Prague, Czech Republic
来源：
CLINICAL THERAPEUTICS | 2008年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S63 / S64
页数：2
相关论文
共 50 条
  • [21] Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease
    Thomaidis, Thomas
    Relle, Manfred
    Reinke, Joerg
    Beck, Michael
    Schwarting, Andreas
    MEDIZINISCHE KLINIK, 2009, 104 (09) : 699 - 703
  • [22] EVOLUTION OF FABRY DISEASE IN MALE GREEK PATIENTS
    Andrikos, A.
    Iatrou, Ch.
    Boletis, J. N.
    Diamandopoulos, A.
    Katsinas, Ch.
    Kalaitzidis, K.
    Galinas, A.
    Xaidara, A.
    Balafa, O.
    Revela, I.
    Dimitroula, V.
    Drakoulogona, O.
    Ouzouni, A.
    Pappas, M.
    Siamopoulos, C.
    CLINICAL THERAPEUTICS, 2009, 31 : S31 - S31
  • [23] THE EVOLUTION OF THE RENAL FUNCTION IN A COHORT OF ITALIAN PATIENTS WITH ADPKD: AN ANALYSIS BY THE JOINT MODEL
    Galliani, Marco
    Vitaliano, Elio
    Chicca, Silvana
    Paone, Antonio
    Di Lullo, Luca
    Tosti, Maria Elena
    Mele, Alfonso
    Calvaruso, Luca
    D'Arrigo, Graziella
    Tripepi, Giovanni Luigi
    Zoccali, Carmine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 95 - 95
  • [24] End-stage renal disease in patients with Fabry disease
    Obrador, GT
    Ojo, A
    Thadhani, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S144 - S146
  • [25] Belgian Fabry Study Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease
    Brouns, Raf
    Thijs, Vincent
    Eyskens, Francois
    Van den Broeck, Marleen
    Belachew, Shibeshih
    Van Broeckhoven, Christine
    Redondo, Patricia
    Hemelsoet, Dimitri
    Fumal, Arnaud
    Jeangette, Sandrine
    Verslegers, Werner
    Baker, Robert
    Hughes, Derralynn
    De Deyn, Peter Paul
    STROKE, 2010, 41 (05) : 863 - 868
  • [26] Fabry Disease in a Cohort of Patients with Hypertrophic Cardiomyopathy in Iceland
    Adalsteinsdottir, B.
    Teekakirikul, P.
    Maron, B. J.
    Danielsen, R.
    Gardarsdottir, M.
    Palsson, R.
    Seidman, C. E.
    Seidman, J. G.
    Gunnarsson, G. T.
    CARDIOLOGY, 2013, 125 : 24 - 24
  • [27] Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
    Zemanek, David
    Januska, Jaroslav
    Honek, Tomas
    Curila, Karol
    Kubanek, Milos
    Sindelarova, Stepanka
    Zahalkova, Lucie
    Klofac, Petr
    Lastuvkova, Eliska
    Lichnerova, Eva
    Aiglova, Renata
    Lhotsky, Jan
    Vondrak, Jiri
    Dostalova, Gabriela
    Taborsky, Milos
    Kasper, David
    Linhart, Ales
    ESC HEART FAILURE, 2022, 9 (06): : 4160 - 4166
  • [28] Fabry disease: Unrecognized ESRD patients and effectiveness of enzyme replacement on renal pathology and function.
    Desnick, RJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 417 - 417
  • [29] GALECTIN-3 STRONGLY ASSOCIATES WITH RENAL FUNCTION, CARDIOMYOPATHY AND FIBROSIS IN PATIENTS WITH FABRY DISEASE
    Drechsler, Christiane
    De Boer, Rudolf
    Oder, Daniel
    Gutjahr-Lengsfeld, Lena
    Ueceyler, Nurcan
    Sommer, Claudia
    Wanner, Christoph
    Nordbeck, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 351 - 351
  • [30] Long-Term Efficacy of Migalastat on Renal Function and Outcomes in Patients with Fabry Disease (FD)
    Bichet, Daniel G.
    Feldt-Rasmussen, Ulla
    Giugliani, Roberto
    Hughes, Derralynn
    Krusinska, Eva
    Veleva-Rotse, Biliana O.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 420 - 421
12345